Announcements

Announcements

 

Paul G. Allen Frontiers Group [to 8 Feb 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BMGF – Gates Foundation [to 8 Feb 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
FEBRUARY 05, 2020
Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response
The foundation will provide up to $100 million to improve detection, isolation and treatment efforts; protect at-risk populations in Africa and South Asia; and accelerate the development of vaccines, drugs and diagnostics.
[See Emergencies above for detail]

 

Bill & Melinda Gates Medical Research Institute [to 8 Feb 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 8 Feb 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
02.04.2020  |
CARB-X funds Pattern Bioscience to develop a new rapid diagnostic for drug-resistant bacterial infections
CARB-X is awarding Pattern Bioscience (formerly operating as Klaris Diagnostics), based in Austin, Texas, US, up to US$6.8 million in non-dilutive funding to develop a rapid identification and antimicrobial susceptibility test (ID/AST) to diagnose drug resistant infections quickly, and provide health professionals with vital information about which pathogen is causing the infection and which antibiotic is most likely to cure the infection.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 8 Feb 2020]
http://cepi.net/
News
CEPI launches new call for proposals to develop vaccines against novel coronavirus, 2019-nCoV
The rolling call is open for two weeks and aims to complement CEPI’s newly developed 2019-nCoV portfolio. All organisations worldwide are invited to apply.
News 03 Feb 2020

UK Government supports CEPI with £20 million additional funding
The UK Government’s Department of Health and Social Care has announced an additional £20 million funding to CEPI to further our mission to advance vaccines against epidemic threats.
News 03 Feb 2020

CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
GSK to make adjuvant technology available to support rapid development of candidate vaccines.
News 03 Feb 2020

 

Clinton Health Access Initiative, Inc. (CHAI) [to 8 Feb 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.

 

EDCTP [to 8 Feb 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.

 

Emory Vaccine Center [to 8 Feb 2020]
http://www.vaccines.emory.edu/
No new digest content identified.

 

European Medicines Agency [to 8 Feb 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
EMA to support development of vaccines and treatments for novel coronavirus
Press release 04/02/2020
[See Emergencies above for detail]

 

European Vaccine Initiative [to 8 Feb 2020]
http://www.euvaccine.eu/news-events
No new digest content identified.

 

FDA [to 8 Feb 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
February 4, 2020 – FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
[See Emergencies above for detail]

 

Fondation Merieux [to 8 Feb 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

 

Gavi [to 8 Feb 2020]
https://www.gavi.org/
News
Global measles vaccination drive to protect up to 45 million children
5 Feb 2020
{See Milestones above for detail]

 

GHIT Fund [to 8 Feb 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 

Global Fund [to 8 Feb 2020]
https://www.theglobalfund.org/en/news/
News & Stories
News
Angola: Seeking Better Pathways to Fight Epidemics
05 February 2020

 

Hilleman Laboratories [to 8 Feb 2020]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 8 Feb 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 

IAVI [to 8 Feb 2020]
https://www.iavi.org/newsroom
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
No new digest content identified.

 

IFRC [to 8 Feb 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

IVAC [to 8 Feb 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.

 

IVI [to 8 Feb 2020]
http://www.ivi.int/
Selected IVI News & Announcements
No new digest content identified.

 

JEE Alliance [to 8 Feb 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 8 Feb 2020]
http://www.msf.org/
Latest [Selected Announcements]
Nigeria
Northeast Nigeria: “The conflict is intensifying and the…
Interview 4 Feb 2020

Sudan
Four things you need to know about South Sudanese refugees in…
Project Update 3 Feb 2020

 

National Vaccine Program Office – U.S. HHS [to 8 Feb 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
February 13-14, 2020 NVAC Meeting
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)

 

NIH [to 8 Feb 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
Monday, February 3, 2020
Experimental HIV vaccine regimen ineffective in preventing HIV
No safety concerns found; NIH and partners discontinue vaccinations.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine. This action was taken because an independent data and safety monitoring board (DSMB) found during an interim review that the regimen did not prevent HIV. Importantly, the DSMB did not express any concern regarding participant safety.
The Phase 2b/3 study, named HVTN 702 or Uhambo, began in 2016 and is taking place in South Africa. It was testing an investigational prime-boost vaccine regimen based on the only vaccine regimen ever to show protection from HIV—the regimen tested in the RV144 clinical trial in Thailand led by the U.S. Military HIV Research Program and the Thai Ministry of Health. For HVTN 702, the vaccine regimen was adapted to the HIV subtype Clade C most common in southern Africa, where the pandemic is most pervasive.
“An HIV vaccine is essential to end the global pandemic, and we hoped this vaccine candidate would work. Regrettably, it does not,” said NIAID Director Anthony S. Fauci, M.D. “Research continues on other approaches to a safe and effective HIV vaccine, which I still believe can be achieved.”…

 

PATH [to 8 Feb 2020]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.

 

Sabin Vaccine Institute [to 8 Feb 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 8 Feb 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
No new digest content identified.

 

UNICEF [to 8 Feb 2020]
https://www.unicef.org/media/press-releases
Selected Statements, Press Releases, Reports
Statement
Unleashing Youth Power: A Decade of Accelerating Actions Towards Zero Female Genital Mutilation
Joint statement by UNFPA Executive Director Dr. Natalia Kanem, UNICEF Executive Director Henrietta Fore, UN Women Executive Director Phumzile Mlambo-Ngcuka and WHO Director-General Dr. Tedros Adhanom Ghebreyesus
05/02/2020

Press release
Approximately 1 in 4 survivors of female genital mutilation were cut by a health care provider
Increased prevalence in medicalized FGM obscures global progress on eliminating support for the practice. Twice as many women in high-prevalence countries want the practice to end compared to 20 years ago
05/02/2020

Statement
One year on from peace agreement, millions of children in the Central African Republic remain at risk
Statement attributable to UNICEF’s Representative in CAR, Christine Muhigana
05/02/2020

Press release
Global measles vaccination drive to protect upto 45 million children
Vaccination campaigns in seven countries to tackle rise in measles cases worldwide
05/02/2020
[See Milestones above for detail]

Press release
UN agencies raise alarm in the Central Sahel where millions face hunger amid rapidly escalating humanitarian crisis
Joint UNFAO, UNICEF and WFP press release
03/02/2020

Press release
Mexico: An estimated 700 migrant children stranded in Matamoros near U.S. border
UNICEF expanding access to protection, psychosocial, water and sanitation services for children and families in need
01/02/2020

Statement
More than 6,500 children forced to flee in northwest Syria every day for past week
Statement by UNICEF Executive Director Henrietta Fore
01/02/2020

 

Vaccination Acceptance Research Network (VARN) [to 8 Feb 2020]
https://vaccineacceptance.org/news.html#header1-2r
No new digest content identified.

 

Vaccine Confidence Project [to 8 Feb 2020]
http://www.vaccineconfidence.org/
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 8 Feb 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

 

Wellcome Trust [to 8 Feb 2020]
https://wellcome.ac.uk/news
Opinion | 5 February 2020
Director’s update: UK and EU leaders must now agree a strong deal for science
by Jeremy Farrar

Opinion | 5 February 2020
Value people as well as papers to improve research culture
by Christopher Jackson

Opinion | 5 February 2020
5 things we learned about changing behaviours for antibiotic stewardship
by Sian Williams

Opinion | 3 February 2020
How we’re using Researchfish data to inform what we do
by Chonnettia Jones

 

The Wistar Institute [to 8 Feb 2020]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

 

World Organisation for Animal Health (OIE) [to 8 Feb 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 8 Feb 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.

 

BIO [to 8 Feb 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 8 Feb 2020]
http://www.dcvmn.org/
News
Advanced Pharmacovigilance workshop and WG meeting
16 March 2020 to 19 March 2020, Shanghai / China

 

IFPMA [to 8 Feb 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
WHO EB 146 Agenda Item 20: Data and innovation: draft global strategy on digital health
07 February 2020
This Statement is made by the International Federation of Pharmaceutical Manufacturers and Associations, the Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association, and the Global Self-Care Federation (previously called the World Self-Medication Industry).
We stand with WHO and Member States in the digital transformation of healthcare and are encouraged by the work achieved by the WHO, particularly since the creation of the WHO Department of Digital Health.
Through collaborations and partnerships of the healthcare industry with governments, NGOs, and other stakeholders, we are already supporting the road to UHC by delivering innovative solutions to improve treatment outcomes, access to care, research, and by co-building an ecosystem where digital technologies meaningfully complement resilient, patient-centred health systems.
The draft Global Strategy sets forth an ambitious plan, tackling key aspects of digital technologies for health, such as those of legal, ethical and regulatory frameworks, health data governance including privacy and security, and interoperability frameworks, with a view towards harmonization. However, realizing these ambitions will not be possible without a coordinated multi-stakeholder approach, including patients, governments, national regulators, health care professionals, academia, and the healthcare industry.
Appropriate use of health data and establishment of appropriate global standards, in particular on EMRs, can significantly support evidence-based healthcare solutions, but governments will also need to commit to the necessary steps in line with the Global Strategy and dedicate appropriate resources to the implementation and scale-up of this transformation.
We call strongly on WHO to align its work on digital technologies with other international organisations and to meaningfully engage the healthcare industry in realizing the potential of digital technologies for health. We further call on Member States to recognize the benefits of new technologies for health, and to foster an ecosystem which robustly assesses outcomes and rewards true innovation. We look forward to continuing a constructive and inclusive debate on digital health.

 

PhRMA [to 8 Feb 2020]
http://www.phrma.org/
Selected Press Releases, Statements
Press Release
PhRMA 2020 Special 301 Report Urges USTR to Protect U.S. Innovation
WASHINGTON, D.C. (February 6, 2020) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today called on the Office of the United States Trade Representative (USTR) to defend American biopharmaceutical innovators and jobs by ending market access and intellectual property barriers in 24 leading economies around the world.
In its submission for USTR’s  2020 Special 301 Report, PhRMA called on the Trump administration to address discriminatory market access practices abroad that free ride on American innovation and put U.S. jobs and exports at risk. The report urges action to reverse compulsory licensing in Malaysia and to end damaging pricing policies in several markets, including Canada, Japan and South Korea…